科研成果详情

题名Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism
作者
发表日期2024-04-01
发表期刊Chemico-biological interactions   影响因子和分区
语种英语
原始文献类型Journal Article
关键词Interaction Myricetin Pharmacokinetic Quercetin Ticagrelor
其他关键词MYOCARDIAL-INFARCTION ; PHARMACOKINETICS ; PREVENTION ; PHARMACODYNAMICS ; INHIBITORS
摘要The aim of this study was to investigate the potential drug-drug interactions (DDIs) between ticagrelor and other drugs as well as their underlying mechanisms. Rat liver microsome (RLM) reaction system was used to screen potential DDIs in vitro, and ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) was applied to detect the levels of ticagrelor and AR-C124910XX, the main metabolite of ticagrelor. A total of 68 drugs were screened, 11 of which inhibited the production of AR-C124910XX to 20% or less, especially two flavonoids (myricetin and quercetin). The half-maximal inhibitory concentration (IC50) of myricetin on ticagrelor was 11.51 ± 0.28 μM in RLM and 17.96 ± 0.54 μM in human liver microsome (HLM). The IC50 of quercetin in inhibiting ticagrelor in RLM and HLM was 16.92 ± 0.49 μM and 60.15 ± 0.43 μM, respectively. They all inhibited the metabolism of ticagrelor through a mixed mechanism. In addition, Sprague-Dawley (SD) rats were used to study the interactions of ticagrelor with selected drugs in vivo. We found that the main pharmacokinetic parameters including AUC (0-t), AUC (0-∞) and Cmax of ticagrelor were significantly increased when ticagrelor was combined with these two flavonoids. Our results suggested that myricetin and quercetin of flavonoids both had significant effects on the metabolism of ticagrelor, providing reference data for the clinical individualized medication of ticagrelor
出版者ELSEVIER IRELAND LTD
ISSN0009-2797
EISSN1872-7786
卷号392
DOI10.1016/j.cbi.2024.110924
页数7
WOS类目Biochemistry & Molecular Biology ; Pharmacology & Pharmacy ; Toxicology
WOS研究方向Biochemistry & Molecular Biology ; Pharmacology & Pharmacy ; Toxicology
WOS记录号WOS:001194029400001
收录类别PUBMED ; SCOPUS ; SCIE
在线发表日期2024-02
URL查看原文
PubMed ID38401715
SCOPUSEID2-s2.0-85186742215
通讯作者地址[Xu, Ren-ai]The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China ; [Lin, Jingjing]The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China
Scopus学科分类Toxicology
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/207731
专题药学院(分析测试中心)
附属第一医院
药学院(分析测试中心)_分子药理研究与教学中心
通讯作者Lin, Jingjing; Xu, Ren-ai
作者单位
1.The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China;
2.Institute of Molecular Toxicology and Pharmacology,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhejiang,Wenzhou,China
第一作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院;  药学院(分析测试中心)
通讯作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Wang, Jing,Hu, Yingying,Li, Qingqing,et al. Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism[J]. Chemico-biological interactions,2024,392.
APA Wang, Jing, Hu, Yingying, Li, Qingqing, Liu, Ya-nan, Lin, Jingjing, & Xu, Ren-ai. (2024). Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism. Chemico-biological interactions, 392.
MLA Wang, Jing,et al."Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism".Chemico-biological interactions 392(2024).

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Wang, Jing]的文章
[Hu, Yingying]的文章
[Li, Qingqing]的文章
百度学术
百度学术中相似的文章
[Wang, Jing]的文章
[Hu, Yingying]的文章
[Li, Qingqing]的文章
必应学术
必应学术中相似的文章
[Wang, Jing]的文章
[Hu, Yingying]的文章
[Li, Qingqing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。